Bone marrow oxalosis with pancytopenia in a patient with short bowel syndrome: Report of a case and review of the literature

被引:5
作者
Bering, Jamie L. [1 ]
Wiedmeier-Nutor, Julia E. [2 ]
Sproat, Lisa [2 ]
DiBaise, John K. [1 ]
机构
[1] Mayo Clin Arizona, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA
[2] Mayo Clin Arizona, Div Hematol & Oncol, Phoenix, AZ USA
关键词
enteric oxalosis; gastroenterology; hematology; intestinal failure; parenteral nutrition; renal disease; short bowel syndrome; KIDNEY-TRANSPLANTATION; ENTERIC HYPEROXALURIA; SECONDARY; OXALATE; MANAGEMENT; STONES;
D O I
10.1002/jpen.2453
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Systemic oxalosis is a condition in which calcium oxalate crystals deposit into various bodily tissues. Although this may occur as the result of a rare primary syndrome in which an error of glyoxylate metabolism causes an overproduction of oxalate, it is more often seen as a secondary process characterized by increased enteric oxalate absorption. Here, we describe a patient with short bowel syndrome on long-term parenteral nutrition support who developed a unique manifestation of systemic oxalosis, leading to deposition of oxalate crystals within the bone marrow contributing to pancytopenia. In this report, in addition to reviewing the literature on this presumably rare manifestation of oxalosis, we also discuss its pathogenesis in the setting of short bowel syndrome and its management, including prevention.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 20 条
[1]   The management of patients with enteric hyperoxaluria [J].
Asplin, John R. .
UROLITHIASIS, 2016, 44 (01) :33-43
[2]   Short Bowel Syndrome in Adults [J].
Bering, Jamie ;
DiBaise, John K. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (06) :876-883
[3]  
Bernhardt WM, 2006, CLIN NEPHROL, V65, P216
[4]  
Bhasin Bhavna, 2015, World J Nephrol, V4, P235, DOI 10.5527/wjn.v4.i2.235
[5]   Combined Kidney and Intestinal Transplantation in Patients With Enteric Hyperoxaluria Secondary to Short Bowel Syndrome [J].
Ceulemans, L. J. ;
Nijs, Y. ;
Nuytens, F. ;
De Hertogh, G. ;
Claes, K. ;
Bammens, B. ;
Naesens, M. ;
Evenepoel, P. ;
Kuypers, D. ;
Vanrenterghem, Y. ;
Monbaliu, D. ;
Pirenne, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (07) :1910-1914
[6]  
DiBaise JK., 2022, YAMADAS TXB GASTROEN, V7th ed, P1168
[7]   Oxalobacter sp reduces urinary oxalate excretion by promoting enteric oxalate secretion [J].
Hatch, M ;
Cornelius, J ;
Allison, M ;
Sidhu, H ;
Peck, A ;
Freel, RW .
KIDNEY INTERNATIONAL, 2006, 69 (04) :691-698
[8]  
Hesse A, 1999, J AM SOC NEPHROL, V10, pS329
[9]   Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts [J].
Karaolanis, Georgios ;
Lionaki, Sophia ;
Moris, Demetrios ;
Palla, Viktoria-Varvara ;
Vernadakis, Spiridon .
TRANSPLANTATION REVIEWS, 2014, 28 (04) :182-187
[10]   Bone Marrow Oxalosis in a Patient With Pancytopenia Following Bilateral Nephrectomy [J].
Kim, Moon Jin ;
Park, Pil-Whan ;
Seo, Yiel-Hea ;
Kim, Kyung-Hee ;
Seo, Ja Young ;
Jeong, Ji-Hun ;
Lee, Hwan Tae ;
An, Jungsuk ;
Ahn, Jeong-Yeal .
ANNALS OF LABORATORY MEDICINE, 2016, 36 (03) :266-267